文传商讯
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmis
2026-02-04 00:03:55
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY for CDKL5 Deficienc
2026-02-04 00:03:55
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity
2026-01-30 23:00:44



